For Media Inquiries, Please Contact:
Apotex Inc.
150
Signet Drive,
North York,
ON, M9L 1T9
Canada
Email
Press Center
-
April 2, 2024Canada's largest pharmaceutical company, Apotex Inc. ("Apotex") and Searchlight Pharma Inc. ("Searchlight"), one of Canada's fastest growing companies, announced today that they have reached an agreement whereby Apotex will acquire Searchlight.
-
February 16, 2024Harrow, Inc., a leading U.S. eyecare pharmaceutical company, and Apotex Inc., Canada’s largest pharmaceutical company, today jointly announced an exclusive out-licensing agreement under which Apotex will market and distribute VERKAZIA® and over-the-counter (OTC) Cationorm® PLUS in the Canadian market, and concurrently, pursue market approval in Canada for VEVYE®, IHEEZO®, and ZERVIATE®.
-
August 9, 2023
-
August 9, 2023
-
April 3, 2023
-
February 1, 2023
-
December 16, 2022
-
September 28, 2022Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability
-
July 27, 2022
-
July 20, 2022Apotex Inc., Canada's leading pharmaceutical manufacturer of generic medicines, announced today the launch of APO-Apixaban™ tablets, Canada's first generic alternative to Eliquis®
-
May 17, 2022
-
April 26, 2022
-
January 19, 2022
-
November 30, 2021
-
November 9, 2021
-
September 30, 2021
-
September 27, 2021
-
September 1, 2021
-
April 29, 2021
-
April 15, 2021